Per Damkier1,2, Louise Skov Christensen3, Anne Broe1,3. 1. Department of Clinical Biochemistry & Pharmacology, Odense University Hospital, Odense, Denmark. 2. Department of Clinical Research, University of Southern Denmark, Odense, Denmark. 3. Department of Clinical Pharmacology and Pharmacy, Institute of Public Health, University of Southern Denmark, Odense, Denmark.
Abstract
AIMS: To analyse prescribing patterns during pregnancy for antipsychotics (APs), antidepressants (ADs) and mood-stabilizing antiepileptics (AEDs) in Denmark from 2000 to 2016. METHODS: Data were obtained from the Danish Medical Birth Register, the Register for Legally Induced Abortions, the Danish National Patient Register and the Register of Medicinal Product Statistics. Data were linked through a unique personal identifier by Statistics Denmark. RESULTS: The use of APs increased 2.5-fold from a prevalence of 1.5 per 1000 pregnancies to 3.8 for pregnancies ending in a delivery. Use of mood-stabilizing AEDs increased from a prevalence of 0.1 to 2.1 during the study period. The prevalence for APs and mood-stabilizing AEDs was nearly twice as high for pregnancies ending in miscarriage or termination compared to pregnancies ending in delivery. A marked increase in the prevalence of ADs use during pregnancy was seen from 2000-2011 (from 6 to 41 per 1000 pregnancies ending in a delivery) but appears slightly in decline. Age, smoking, obesity and social status were generally associated with increased use of psychotropic drugs. CONCLUSIONS: The use of APs, ADs and mood-stabilizing AEDs during pregnancy has increased substantially in Denmark from 2000-2016. The use of ADs appears to be slightly in decline since 2011.
AIMS: To analyse prescribing patterns during pregnancy for antipsychotics (APs), antidepressants (ADs) and mood-stabilizing antiepileptics (AEDs) in Denmark from 2000 to 2016. METHODS: Data were obtained from the Danish Medical Birth Register, the Register for Legally Induced Abortions, the Danish National Patient Register and the Register of Medicinal Product Statistics. Data were linked through a unique personal identifier by Statistics Denmark. RESULTS: The use of APs increased 2.5-fold from a prevalence of 1.5 per 1000 pregnancies to 3.8 for pregnancies ending in a delivery. Use of mood-stabilizing AEDs increased from a prevalence of 0.1 to 2.1 during the study period. The prevalence for APs and mood-stabilizing AEDs was nearly twice as high for pregnancies ending in miscarriage or termination compared to pregnancies ending in delivery. A marked increase in the prevalence of ADs use during pregnancy was seen from 2000-2011 (from 6 to 41 per 1000 pregnancies ending in a delivery) but appears slightly in decline. Age, smoking, obesity and social status were generally associated with increased use of psychotropic drugs. CONCLUSIONS: The use of APs, ADs and mood-stabilizing AEDs during pregnancy has increased substantially in Denmark from 2000-2016. The use of ADs appears to be slightly in decline since 2011.
Authors: R Hamish McAllister-Williams; David S Baldwin; Roch Cantwell; Abby Easter; Eilish Gilvarry; Vivette Glover; Lucian Green; Alain Gregoire; Louise M Howard; Ian Jones; Hind Khalifeh; Anne Lingford-Hughes; Elizabeth McDonald; Nadia Micali; Carmine M Pariante; Lesley Peters; Ann Roberts; Natalie C Smith; David Taylor; Angelika Wieck; Laura M Yates; Allan H Young Journal: J Psychopharmacol Date: 2017-04-25 Impact factor: 4.153
Authors: Jenneke van Ditzhuijzen; Margreet Ten Have; Ron de Graaf; Carolus H C J van Nijnatten; Wilma A M Vollebergh Journal: Perspect Sex Reprod Health Date: 2017-04-28
Authors: Irene Petersen; Rachel L McCrea; David J P Osborn; Stephen Evans; Vanessa Pinfold; Phil J Cowen; Ruth Gilbert; Irwin Nazareth Journal: Schizophr Res Date: 2014-08-27 Impact factor: 4.939